Eton Pharmaceuticals (ETON) Gains from Sales and Divestitures (2019 - 2025)
Eton Pharmaceuticals' (ETON) quarterly Gains from Sales and Divestitures came in at $159150.0 in Q4 2025, up 76.05% year-on-year from $90402.0 in Q4 2024, and up 89.01% quarter-over-quarter from $84204.0 in Q3 2025.
Eton Pharmaceuticals (ETON) Gains from Sales and Divestitures (2019 - 2025) Analysis & Trends
Eton Pharmaceuticals has disclosed Gains from Sales and Divestitures across 6 years of filings, most recently posting $159150.0 for Q4 2025.
- Gains from Sales and Divestitures for Q4 2025 came in at $159150.0, up 76.05% year-over-year; the trailing twelve-month figure through Dec 2025 was $159150.0 (up 76.05% YoY), and the FY2025 annual result was $159150.0, up 76.05% from the prior year.
- Gains from Sales and Divestitures came in at $159150.0 for Q4 2025 at Eton Pharmaceuticals, up from $84204.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $159150.0 in Q4 2025 to a low of $889.0 in Q2 2025.
- The 4-year median for Gains from Sales and Divestitures is $90402.0 (2024), against an average of $76930.8.
- Peak annual rise in Gains from Sales and Divestitures reached 76.05% in 2025, while the deepest fall reached 6.86% in 2025.
- Eton Pharmaceuticals' Gains from Sales and Divestitures stood at $7595.0 in 2021, then soared by 1103.45% to $91402.0 in 2023, then fell by 1.09% to $90402.0 in 2024, then jumped by 76.05% to $159150.0 in 2025.
- The last three Gains from Sales and Divestitures figures came in at $159150.0 (Q4 2025), $84204.0 (Q3 2025), and $889.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Eton Pharmaceuticals | 820.42 Mn | 794.48 Mn | 13.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 159,150.00 |
| Dec 31, 2025 | 159,150.00 |
| Sep 30, 2025 | 84,204.00 |
| Sep 30, 2025 | 84,204.00 |
| Jun 30, 2025 | 889.00 |
| Jun 30, 2025 | 889.00 |
| Dec 31, 2024 | 90,402.00 |
| Dec 31, 2024 | 90,402.00 |
| Sep 30, 2024 | 90,402.00 |
| Sep 30, 2024 | 90,402.00 |
| Dec 31, 2023 | 91,402.00 |
| Dec 31, 2023 | 91,402.00 |
| Sep 30, 2023 | 91,402.00 |
| Sep 30, 2023 | 91,402.00 |
| Dec 31, 2021 | 7,595.00 |
| Dec 31, 2021 | 7,595.00 |
| Dec 31, 2020 | 7,595.00 |
| Dec 31, 2020 | 7,595.00 |
| Sep 30, 2019 | 312,500.00 |
| Sep 30, 2019 | 312,500.00 |